Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease

Netherlands Journal of Medicine

Volumn 69, Issue 5, 2011, Pages 229-236

  van Zuilen, A D ^a   Blankestijn, P J ^a   van Buren, M ^b   ten Dam, M A G J ^c   Kaasjager, K A H ^d   Ligtenberg, G ^e   Sijpkens, Y W J ^f   Sluiter, H E ^g   van de Ven, P J G ^h   Vervoort, G ⁱ   Vleming, L ^b   Bots, M L ^a   Wetzels, J F M ⁱ  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e Dutch Health Care Insurance Board ^*  (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g DEVENTER HOSPITAL   (Netherlands)

^h Maasstad Hospital Rotterdam   (Netherlands)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood pressure; Centre differences; Chronic kidney disease; Epidemiology; Therapeutic inertia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; LOOP DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DATA BASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULONEPHRITIS; HEALTH CARE QUALITY; HOSPITAL; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OSCILLOMETRY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL MODEL; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HOSPITALS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSCILLOMETRY;

EID: 79961223667     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13.
2. Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008 Apr;121(4):332-40.
3. Klahr S, Levey AS, Beck G, Caggiula AW, Hunsicker L, Kusek JW, et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease. N Engl J Med. 1994 Mar 31;330(13):877-84.
4. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet. 1998 Oct 17;352(9136):1252-6.
5. Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010 Mar;55(3):441-51.
6. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd B. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis. 2001 Mar;37(3):484-9.
7. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006 Feb;69(3):538-45.
8. Banegas JR, Segura J, Ruilope LM, Luque M, Garcia-Robles R, Campo C, et al. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension. 2004 Jun;43(6):1338-44.
9. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-Related Barriers to the Effective Management of Uncontrolled Hypertension. Arch Intern Med. 2002 Feb 25;162(4):413-20.
10. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors Associated With Hypertension Control in the General Population of the United States. Arch Intern Med. 2002 May 13;162(9):1051-8.
11. Van Zuilen AD, Blankestijn PJ, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, et al. Quality of care in patients with chronic kidney disease is determined by hospital specific factors. Nephrol Dial Transplant. 2010 Nov;25(11):3647-54.
12. Van Zuilen AD, Wetzels JF, Blankestijn PJ, Bots ML, Van Buren M, Ten Dam MA, et al. Rationale and design of the MASTERPLAN study: Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. J Nephrol. 2005 Jan;18(1):30-4.
13. Van Zuilen AD, Van der Tweel I, Blankestijn PJ, Bots ML, Van Buren M, Ten Dam MA, et al. Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232]. Trials. 2006;7:8.
14. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004 May 1;43(5 Suppl 1):S1-290.
15. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995 Dec;13(12 Pt 1):1377-90.
16. Wendel-Vos GCW, Schuit AJ, Saris WHM, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003 Dec;56(12):1163-9.
17. Levey AS, Greene T, Kusek JW, Beck GL, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000 Sep 9;11:a0828.
18. Kenward MG, Carpenter J. Multiple imputation: current perspectives. Stat Methods Med Res. 2007 Jun;16(3):199-218.
19. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology-A practical guide. Cambridge: Cambridge University Press; 2003.
20. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003 May 14;289(18):2363-9.
21. Becker GJ, Wheeler DC. Blood pressure control in CKD patients: why do we fail to implement the guidelines? Am J Kidney Dis. 2010 Mar;55(3):415-8.
22. Agyemang C, Ujcic-Voortman J, Uitenbroek D, Foets M, Droomers M. Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: The Amsterdam Health Monitor Survey. J Hypertens. 2006 Nov;24(11):2169-76.
23. Agyemang C, van Hooijdonk C, Wendel-Vos W, Ujcic-Voortman JK, Lindeman E, Stronks K, et al. Ethnic differences in the effect of environmental stressors on blood pressure and hypertension in the Netherlands. BMC Public Health. 2007;7:118.
24. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and Determinants of Medication Adherence in Hypertension Management: Perspective of the Cohort Study of Medication Adherence Among Older Adults. Med Clin North Am. 2009 May;93(3):753-69.
25. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008 May 17;336(7653):1114-7.
26. Ter Wee PM, Jorna AT. [Treatment of patients with chronic renal insufficiency; a guideline for internists]. Ned Tijdschr Geneeskd. 2004 Apr 10;148(15):719-24.